NAG Research Laboratories Inc. (NRL) is a California based innovative IP driven company focusing on new drug discovery, novel biotechnology products. The company also offers pre-clinical research services and a unique line of herbal and nutraceuticals. NRL's corporate offices are located in Fremont, CA, USA with subsidiary branches in Bangalore, India. NRL’s team consists of highly specialized scientists with over 30 years of experience in biotechnology product development and drug discovery research activities. NRL operates it's activities through four major divisions:
RENOVEL DISCOVERIES (DRUG DISCOVERY)
RENOVEL Pharma is an integrated drug discovery company focused on the discovery and development of natural product based human therapeutics to fill unmet medical needs. RENOVEL's mission is to utilize it's innovative Natural Product Creative Compound (NPCC) technology to rapidly identify single molecular entities isolated from Indian medicinal plants into safe and effective medicines. We have a pipeline of patened small molecules as pre-clinical drug candidates for the treatment of a wide range of human diseases including metabolic diseases (Diabetes, Obesity, Hyperlipidemia), inflammatory diseases (Rheumatoid Arthritis, IBD, Psoriasis), central nervous system disorders (Multiple Sclerosis and Alzheimer) and Cancer (breast cancer, lung cancer, prostate cancer).
The Biotechnology Division of NRL develops proprietary novel kits and reagents utilized by academic, biotechnology and Pharmaceutical industries in the fields of protein biochemistry, molecular biology, immunology and drug discovery research. Currently the company has products for Electrophoresis, Electro-blotting, Protein Biochemistry and Proteomics. NRL has introduced over 20 new products and markets these products directly or through distributors world-wide. All products in the Biotechnology division are discovered, developed and manufactured by NRL in its USA (California) location.
NRL provides services to academic institutions, biotechnology and pharmaceutical industries with a team that brings 30+ years of experience in pre-clinical research. NRL offers animal models, pharmacokinetics, pharmacodynamics, ADME and toxicology studies. The company has the experience of conducting over 100 animal models in more than 20 disease areas. Our team has taken more than 10 drugs from discovery to Phase II clinical trials through US-FDA and European regulatory agencies. Currently the company provides services in USA and through it's subsidiary in Bangalore, India.
HERBALYN is a subsidiary of NRL that develops unique proprietary herbal products with enhanced efficacy of natural product extracts. HERBALYN has developed a unique patentable line of products that combines natural products with a propietary excipient for enhanced efficacy. Currently HERBALYN has over 200 new lines of alternative medicines spanning major therapeutic areas such as general health care, chronic diseases, cosmetics, sports medicine and nutrition. HERBALYN strength includes advanced in vivo studies, formal toxicological evaluations, and clinical trials with patentable products.
Next generation of
Discovery, Development and Commercialization
Next Generation of Discovery, Development and Commercialization
Copyright NAG Research Laboratories Inc. 2010.
USA Corporate Headquarters:
NAG ResearchLaboratories Inc.
Bayside Technology Park
46500 Fremont Boulevard Suites 704-706
Fremont, CA 94538, USA
